Evidence map›Paper›PMID 24317393›Full record

ArticleThe Journal of investigative dermatology2014

Reversal of murine epidermal atrophy by topical modulation of calcium signaling.

Basile Darbellay, Laurent Barnes, Wolf-Henning Boehncke, Jean-Hilaire Saurat, Gürkan Kaya

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in The Journal of investigative dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Activation of Lysosomal Retrograde Transport Triggers TPC1-IP3R1 CaAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  2. Article
  3. Article
  4. Store-operated calcium channels in skin.Frontiers in physiology · 2022
    Review
  5. Skin Barrier and Calcium.Annals of dermatology · 2018
    Review
  6. Article
  7. Calcium, Orai1, and epidermal proliferation.The Journal of investigative dermatology · 2014
    Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Basile DarbellayDepartment of Dermatology, University Hospital of Geneva, Geneva, Switzerland. Electronic address: Basile.darbellay@unige.ch.
Laurent BarnesDepartment of Dermatology, University Hospital of Geneva, Geneva, Switzerland.
Wolf-Henning BoehnckeDepartment of Dermatology, University Hospital of Geneva, Geneva, Switzerland.
Jean-Hilaire SauratSwiss Center for Applied Human Toxicology, University of Geneva, Geneva, Switzerland.
Gürkan KayaDepartment of Dermatology, University Hospital of Geneva, Geneva, Switzerland.
University Hospital of Geneva · CHUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytosolic Ca(2+) signals are performed by Ca(2+) releases from the endoplasmic reticulum and Ca(2+) influx from the extracellular medium. Releases rely on the refilling of the intracellular Ca(2+) stores by the Ca(2+) influx "Store-Operated Calcium Entry" (SOCE) via the channel Orai1. Here we show that Orai1 expression, SOCE amplitude, and epidermal proliferation are decreased in the epidermis of patients with skin fragility when compared with aged nonatrophic skin. Epidermal atrophy was induced in mice by the inhibition of Orai1 with small interfering RNA and the topical application of a SOCE blocker BTP2. The inhibition of Orai1 impaired the heparin-binding epidermal growth factor (HB-EGF)-induced Ca(2+) influxes and fully prevented the mitogen effect of HB-EGF in primary human keratinocytes. Importantly, epidermal proliferation correlated with Orai1 expression in mice. Conversely, the topical application of an Orai1 activator, the benzohydroquinone (BHQ), increased the epidermal thickness and proliferation, whereas the pro-proliferative effect of BHQ was prevented by the inhibition of Orai1. Finally, the topical application of BHQ reversed the epidermal atrophy induced by corticosteroids in mice. The topical modulation of Ca(2+) signals may thus be a promising therapeutic strategy in dermatology.

Indexed as

Calcium SignalingAnilidesAnimalsAtrophyCalciumCalcium ChannelsCell ProliferationCytosolEpidermisHeparin-binding EGF-like Growth FactorHumansHydroquinonesIntercellular Signaling Peptides and ProteinsKeratinocytesManganeseMice4-methyl-4'-(3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl)-1,2,3-thiadiazole-5-carboxanilideAnilidesCalciumCalcium ChannelsHBEGF protein, humanHbegf protein, mouseHeparin-binding EGF-like Growth FactorHydroquinonesIntercellular Signaling Peptides and ProteinsManganeseORAI1 ProteinORAI1 protein, humanOrai1 protein, mouseRNA, Small InterferingThiadiazoles

Identifiers

PMID24317393
OpenAlexW1976680976

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.